These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 23843450

  • 1. Plasmacytoid dendritic cells, interferon signaling, and FcγR contribute to pathogenesis and therapeutic response in childhood immune thrombocytopenia.
    Sehgal K, Guo X, Koduru S, Shah A, Lin A, Yan X, Dhodapkar KM.
    Sci Transl Med; 2013 Jul 10; 5(193):193ra89. PubMed ID: 23843450
    [Abstract] [Full Text] [Related]

  • 2. High-dose dexamethasone shifts the balance of stimulatory and inhibitory Fcgamma receptors on monocytes in patients with primary immune thrombocytopenia.
    Liu XG, Ma SH, Sun JZ, Ren J, Shi Y, Sun L, Dong XY, Qin P, Guo CS, Hou M, Peng J.
    Blood; 2011 Feb 10; 117(6):2061-9. PubMed ID: 21131591
    [Abstract] [Full Text] [Related]

  • 3. Intravenous immunoglobulin abrogates dendritic cell differentiation induced by interferon-alpha present in serum from patients with systemic lupus erythematosus.
    Bayry J, Lacroix-Desmazes S, Delignat S, Mouthon L, Weill B, Kazatchkine MD, Kaveri SV.
    Arthritis Rheum; 2003 Dec 10; 48(12):3497-502. PubMed ID: 14674000
    [Abstract] [Full Text] [Related]

  • 4. Mechanistic properties of intravenous immunoglobulin in murine immune thrombocytopenia: support for FcγRIIB falls by the wayside.
    Crow AR, Lazarus AH.
    Semin Hematol; 2016 Apr 10; 53 Suppl 1():S20-2. PubMed ID: 27312158
    [Abstract] [Full Text] [Related]

  • 5. Mechanisms of action of intravenous immunoglobulin in the treatment of immune thrombocytopenia.
    Crow AR, Song S, Siragam V, Lazarus AH.
    Pediatr Blood Cancer; 2006 Oct 15; 47(5 Suppl):710-3. PubMed ID: 16933274
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Tumor Necrosis Factor-α Blockade Corrects Monocyte/Macrophage Imbalance in Primary Immune Thrombocytopenia.
    Zhao Y, Xu P, Guo L, Wang H, Min Y, Feng Q, Hou Y, Sun T, Li G, Ji X, Qiu J, Peng J, Liu X, Hou M.
    Thromb Haemost; 2021 Jun 15; 121(6):767-781. PubMed ID: 33469903
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Dendritic cells modulate platelet activity in IVIg-mediated amelioration of ITP in mice.
    Huang HS, Sun DS, Lien TS, Chang HH.
    Blood; 2010 Dec 02; 116(23):5002-9. PubMed ID: 20699442
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Expression patterns of Th1 and Th2 cytokine genes in childhood idiopathic thrombocytopenic purpura (ITP) at presentation and their modulation by intravenous immunoglobulin G (IVIg) treatment: their role in prognosis.
    Mouzaki A, Theodoropoulou M, Gianakopoulos I, Vlaha V, Kyrtsonis MC, Maniatis A.
    Blood; 2002 Sep 01; 100(5):1774-9. PubMed ID: 12176899
    [Abstract] [Full Text] [Related]

  • 13. Mouse immune thrombocytopenia is associated with Th1 bias and expression of activating Fcγ receptors.
    Nishimoto T, Okazaki Y, Numajiri M, Kuwana M.
    Int J Hematol; 2017 May 01; 105(5):598-605. PubMed ID: 28028748
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Study on the Treatment of ITP Mice with IVIG Sourced from Distinct Sex-Special Plasma (DSP-IVIG).
    Zhang W, Yuan X, Wang Z, Xu J, Ye S, Jiang P, Du X, Liu F, Lin F, Zhang R, Ma L, Li C.
    Int J Mol Sci; 2023 Nov 06; 24(21):. PubMed ID: 37958975
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. FcγRIIa and FcγRIIIa polymorphisms in childhood primary immune thrombocytopenia: implications for disease pathogenesis and outcome.
    Papagianni A, Economou M, Tragiannidis A, Karatza E, Samarah F, Gombakis N, Athanassiadou-Piperopoulou F, Vavatsi-Christaki N, Athanassiou-Metaxa M.
    Blood Coagul Fibrinolysis; 2013 Jan 06; 24(1):35-9. PubMed ID: 23249566
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.